Tsakraklides V, Krogh K, Wang L, Bizario J C, Larson R E, Espreafico E M, Wolenski J S
Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, CT 06520-8103, USA.
J Cell Sci. 1999 Sep;112 ( Pt 17):2853-65. doi: 10.1242/jcs.112.17.2853.
Class-V myosins are two-headed actin-based mechanoenzymes that function in the transport and subcellular localization of organelles and possibly in the outgrowth of cellular processes. To determine which domains of myosin-V are involved in intracellular localization of this motor protein, we have expressed fusions of the green fluorescent protein with segments from two distinct myosin-V heavy chains. The expression patterns of constructs encoding four different domains of chick brain myosin-Va were compared to a single construct encoding the globular tail region of mouse myosin-Vb. In transfected mouse melanocytes, expression of the NH(2)-terminal head (catalytic domain) of chick brain myosin-Va codistributed with actin filaments throughout the cytoplasm. A similar construct encoding the myosin-Va head with the associated neck (light chain binding sites), also codistributed with actin filaments. The GFP-head-neck peptide was also highly concentrated in the tips of filopodia in B16 melanocytes wild type for myosin-Va (MYO5a gene), but was concentrated throughout the entire filopodia of S91-6 melanocytes derived from dilute mice with mutations in the MYO5a gene. Evidence is also presented that the globular tail of myosin-Va, but not myosin-Vb, targets this motor molecule to the centrosome as confirmed by colocalization in cells stained with antibodies to (gamma)-tubulin. Expression of the GFP-myosin-Va globular tail causes displacement of endogenous myosin-V from centrosomes as visualized by immunolabeling with antibodies to the head domain of myosin-V. Treatment with the microtubule-disrupting drug nocodazole markedly reduces myosin-V staining at the centrosome. In contrast, there was no detectable diminution of myosin-V staining at the centrosome in cells treated with the actin filament-disrupting drug cytochalasin D. Thus, while localization of the myosin-V motor domain to actin-rich regions is consistent with conventional models of actomyosin-based motility, localization to the centrosome occurs in the complete absence of the myosin-V motor domain and is dependent on intact microtubules.
V 类肌球蛋白是基于肌动蛋白的双头机械酶,在细胞器的运输和亚细胞定位中发挥作用,也可能参与细胞突起的生长。为了确定肌球蛋白-V 的哪些结构域参与这种运动蛋白的细胞内定位,我们将绿色荧光蛋白与来自两种不同肌球蛋白-V 重链的片段进行了融合表达。将编码鸡脑肌球蛋白-Va 四个不同结构域的构建体的表达模式与编码小鼠肌球蛋白-Vb 球状尾部区域的单个构建体进行了比较。在转染的小鼠黑素细胞中,鸡脑肌球蛋白-Va 的 NH(2)-末端头部(催化结构域)的表达与肌动蛋白丝在整个细胞质中共分布。一个编码带有相关颈部(轻链结合位点)的肌球蛋白-Va 头部的类似构建体,也与肌动蛋白丝共分布。GFP-头部-颈部肽在野生型肌球蛋白-Va(MYO5a 基因)的 B16 黑素细胞的丝状伪足尖端也高度浓缩,但在来自 MYO5a 基因突变的稀释小鼠的 S91-6 黑素细胞的整个丝状伪足中都有浓缩。也有证据表明,肌球蛋白-Va 的球状尾部而非肌球蛋白-Vb,将这种运动分子靶向到中心体,这通过用抗γ-微管蛋白抗体染色的细胞中的共定位得到证实。GFP-肌球蛋白-Va 球状尾部的表达导致内源性肌球蛋白-V 从中心体移位,这通过用抗肌球蛋白-V 头部结构域抗体进行免疫标记可视化。用微管破坏药物诺考达唑处理显著降低了中心体处的肌球蛋白-V 染色。相反,在用肌动蛋白丝破坏药物细胞松弛素 D 处理的细胞中,未检测到中心体处的肌球蛋白-V 染色减少。因此,虽然肌球蛋白-V 运动结构域定位于富含肌动蛋白的区域与基于肌动球蛋白的传统运动模型一致,但定位于中心体是在完全没有肌球蛋白-V 运动结构域的情况下发生的,并且依赖于完整的微管。